10th Jan 2008 08:00
Futura Medical PLC10 January 2008 Draft release 10 January 2008 Futura Medical plc ("Futura" or "the Company") Director's Share Transfer Futura Medical plc (AIM: FUM), the pharmaceutical group that develops innovativeproducts for consumer healthcare, announces the following transfer of ordinaryshares in the Company by Anthony Clayden, Finance Director. There is no changein Mr Clayden's total shareholding in the Company, or the beneficial ownershipof Mr Clayden's shares, as a result of the transfer. On 9 January 2008, MrClayden authorised the transfer of 240,305 of his ordinary shares in the Companyinto his Hargreaves Lansdown Vantage Fund and Share account. For further information:Futura Medical plcJames Barder, Chief Executive Tel: +44 (0) 1483 685 670mail to: [email protected] www.futuramedical.co.uk Media enquiries:Buchanan CommunicationsMark Court / Rebecca Skye Dietrich Tel: +44 (0) 20 7466 5000 Nominated Adviser:Canaccord Adams LimitedMark Williams / Erin Needra Tel: +44 (0) 20 7050 6500 This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Futura Medical